KMDA
Price
$6.64
Change
+$0.02 (+0.30%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
306.49M
32 days until earnings call
SGIOY
Price
$8.37
Change
-$0.04 (-0.48%)
Updated
Apr 24 closing price
Capitalization
12.4B
17 days until earnings call
Ad is loading...

KMDA vs SGIOY

Header iconKMDA vs SGIOY Comparison
Open Charts KMDA vs SGIOYBanner chart's image
Kamada
Price$6.64
Change+$0.02 (+0.30%)
Volume$500
Capitalization306.49M
Shionogi & Co
Price$8.37
Change-$0.04 (-0.48%)
Volume$35.92K
Capitalization12.4B
KMDA vs SGIOY Comparison Chart
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. SGIOY commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a StrongBuy and SGIOY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (KMDA: $6.62 vs. SGIOY: $8.37)
Brand notoriety: KMDA and SGIOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 30% vs. SGIOY: 45%
Market capitalization -- KMDA: $306.49M vs. SGIOY: $12.4B
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. SGIOY’s [@Pharmaceuticals: Other] market capitalization is $12.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileSGIOY’s FA Score has 2 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • SGIOY’s FA Score: 2 green, 3 red.
According to our system of comparison, SGIOY is a better buy in the long-term than KMDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 5 TA indicator(s) are bullish while SGIOY’s TA Score has 4 bullish TA indicator(s).

  • KMDA’s TA Score: 5 bullish, 4 bearish.
  • SGIOY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KMDA is a better buy in the short-term than SGIOY.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а +1.85% price change this week, while SGIOY (@Pharmaceuticals: Other) price change was +1.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.63%. For the same industry, the average monthly price growth was -1.43%, and the average quarterly price growth was -9.80%.

Reported Earning Dates

KMDA is expected to report earnings on Aug 13, 2025.

SGIOY is expected to report earnings on Aug 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+4.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGIOY($12.4B) has a higher market cap than KMDA($306M). KMDA has higher P/E ratio than SGIOY: KMDA (37.43) vs SGIOY (9.62). SGIOY YTD gains are higher at: 20.260 vs. KMDA (11.817). SGIOY has higher annual earnings (EBITDA): 242B vs. KMDA (22.4M). SGIOY has more cash in the bank: 563B vs. KMDA (55.6M). KMDA has less debt than SGIOY: KMDA (8.82M) vs SGIOY (9.41B). SGIOY has higher revenues than KMDA: SGIOY (427B) vs KMDA (143M).
KMDASGIOYKMDA / SGIOY
Capitalization306M12.4B2%
EBITDA22.4M242B0%
Gain YTD11.81720.26058%
P/E Ratio37.439.62389%
Revenue143M427B0%
Total Cash55.6M563B0%
Total Debt8.82M9.41B0%
FUNDAMENTALS RATINGS
KMDA vs SGIOY: Fundamental Ratings
KMDA
SGIOY
OUTLOOK RATING
1..100
525
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
8383
SMR RATING
1..100
791
PRICE GROWTH RATING
1..100
4741
P/E GROWTH RATING
1..100
7262
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOY's Valuation (28) in the null industry is somewhat better than the same rating for KMDA (75) in the Biotechnology industry. This means that SGIOY’s stock grew somewhat faster than KMDA’s over the last 12 months.

SGIOY's Profit vs Risk Rating (83) in the null industry is in the same range as KMDA (83) in the Biotechnology industry. This means that SGIOY’s stock grew similarly to KMDA’s over the last 12 months.

SGIOY's SMR Rating (1) in the null industry is significantly better than the same rating for KMDA (79) in the Biotechnology industry. This means that SGIOY’s stock grew significantly faster than KMDA’s over the last 12 months.

SGIOY's Price Growth Rating (41) in the null industry is in the same range as KMDA (47) in the Biotechnology industry. This means that SGIOY’s stock grew similarly to KMDA’s over the last 12 months.

SGIOY's P/E Growth Rating (62) in the null industry is in the same range as KMDA (72) in the Biotechnology industry. This means that SGIOY’s stock grew similarly to KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDASGIOY
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
58%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 4 days ago
64%
Declines
ODDS (%)
Bearish Trend 18 days ago
66%
Bearish Trend 2 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Ad is loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SAMVX10.61N/A
N/A
Virtus Ceredex Mid-Cap Value Equity A
LGLAX40.41N/A
N/A
Lord Abbett Growth Leaders A
MDFSX7.17N/A
N/A
Manning & Napier Disciplined Value S
GAMNX9.95N/A
N/A
Gabelli Global Mini Mites AAA
GCVRX21.74N/A
N/A
Goldman Sachs Large Cp Val Insghts R

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and RDY have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and RDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+0.61%
RDY - KMDA
33%
Poorly correlated
+2.34%
NXSCF - KMDA
27%
Poorly correlated
N/A
SGIOY - KMDA
27%
Poorly correlated
-0.48%
INCR - KMDA
26%
Poorly correlated
-6.01%
ASRT - KMDA
25%
Poorly correlated
+4.20%
More

SGIOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGIOY has been loosely correlated with TAK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGIOY jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
-0.48%
TAK - SGIOY
40%
Loosely correlated
-0.46%
ESAIY - SGIOY
36%
Loosely correlated
+0.56%
KMDA - SGIOY
27%
Poorly correlated
+0.61%
SCYX - SGIOY
23%
Poorly correlated
+9.78%
SUPN - SGIOY
22%
Poorly correlated
+1.65%
More